Rasna Therapeutics's total assets for Q2 2024 were $48.61K, an increase of 85.73% from the previous quarter. RASP total liabilities were $2.23M for the fiscal quarter, a 4.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.